Read the latest from Baszucki Group and its partners.
A growing body of scientific evidence suggests the ketogenic diet, long used to treat epilepsy, could be effective for treating schizophrenia and other psychiatric disorders and reducing the often debilitating side effects of antipsychotics.
Health and Human Services Secretary Robert F. Kennedy Jr. says he wants to “make America healthy again.” With HHS updating its Dietary Guidelines for Americans this year, now is his chance. Nearly all Americans are at risk for metabolic disease. It’s time to recommend for them the lower-carb diet.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across multiple institutions, has published a new study that challenges the long-held belief that high cholesterol correlates and even directly causes coronary artery disease, or plaque buildup in the arteries in metabolically healthy individuals.
Baszucki Group today announced the launch of two new initiatives across multiple sites exploring the effectiveness of ketogenic therapy for children and adolescents with bipolar disorder. The participating groups include a family resource center and four academic research institutions offering specialty programs devoted to treating serious mental illness in children and adolescents. These projects aim to develop ketogenic therapy programs and establish pilot data to fuel future randomized control trials and support programs in a youth population.